COX-2-deficient mice are less prone to MPTP-neurotoxicity than wild-type mice
- 1 October 2003
- journal article
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 14 (15) , 1927-1929
- https://doi.org/10.1097/00001756-200310270-00009
Abstract
The primary lesion in Parkinson's disease is the death of dopaminergic neurons in the substantia nigra.The role of cyclooxygenase (COX)-2 in the etiology of Parkinson's disease was explored using COX-2 gene knockout mice. Mortality after injection of I -methyl-4-phanyl-l,2,3,6 tetrahydropyridine (MPTP, a chemical known to cause parkinsonism in humans) in heterozygous COX-2-deficient mice was lower than that in wild-type mice. The number of tyrosine hydroxylase immunoreactive neurons in the substantia nigra pars compacta of MPTP-treated wild-type mice declined to a greater extent than in heterozygous mice. Inhibition of COX-2 protein expression decreased the lesion caused by MPTP and protected the dopaminergic neurons in substantia nigra pars compacta. This result suggested that inhibition of COX-2 has potential therapeutic implications. © 2003 Lippincott Williams & Wilkins.link_to_subscribed_fulltexKeywords
This publication has 7 references indexed in Scilit:
- Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegenerationProceedings of the National Academy of Sciences, 2003
- Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's diseaseSynapse, 2000
- Inflammatory Regulators in Parkinson's Disease: iNOS, Lipocortin-1, and Cyclooxygenases-1 and -2Molecular and Cellular Neuroscience, 2000
- Neuroprotective Strategies in Parkinson's Disease Using the Models of 6‐Hydroxydopamine and MPTPaAnnals of the New York Academy of Sciences, 2000
- Cyclooxygenase knockout miceBiochemical Pharmacology, 1999
- Aspirin and Salicylate Protect Against MPTP‐Induced Dopamine Depletion in MiceJournal of Neurochemistry, 1998
- Prostaglandin H Synthetase‐Mediated Metabolism of Dopamine: Implication for Parkinson's DiseaseJournal of Neurochemistry, 1995